Galderma Group AG (GDERF)
202.50
+2.55
(+1.28%)
USD |
OTCM |
Jun 09, 16:00
Galderma Group Market Cap
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| May 27, 2026 | 46.94B |
| May 26, 2026 | 49.46B |
| May 22, 2026 | 49.74B |
| May 21, 2026 | 53.43B |
| May 20, 2026 | 45.81B |
| May 19, 2026 | 48.00B |
| May 18, 2026 | 48.00B |
| May 15, 2026 | 46.21B |
| May 14, 2026 | 46.39B |
| May 13, 2026 | 46.01B |
| May 12, 2026 | 46.96B |
| May 11, 2026 | 51.21B |
| May 08, 2026 | 48.12B |
| May 07, 2026 | 49.26B |
| May 06, 2026 | 52.98B |
| May 05, 2026 | 49.43B |
| May 04, 2026 | 50.94B |
| May 01, 2026 | 48.51B |
| April 30, 2026 | 50.75B |
| April 29, 2026 | 49.36B |
| April 28, 2026 | 49.45B |
| April 27, 2026 | 49.00B |
| April 24, 2026 | 46.81B |
| April 23, 2026 | 48.58B |
| April 22, 2026 | 45.04B |
| Date | Value |
|---|---|
| April 21, 2026 | 41.19B |
| April 20, 2026 | 48.00B |
| April 17, 2026 | 48.02B |
| April 16, 2026 | 46.97B |
| April 15, 2026 | 45.48B |
| April 14, 2026 | 48.58B |
| April 13, 2026 | 45.36B |
| April 10, 2026 | 48.58B |
| April 09, 2026 | 48.53B |
| April 08, 2026 | 48.58B |
| April 07, 2026 | 44.33B |
| April 06, 2026 | 46.67B |
| April 02, 2026 | 44.33B |
| April 01, 2026 | 45.74B |
| March 31, 2026 | 43.79B |
| March 30, 2026 | 41.65B |
| March 27, 2026 | 45.81B |
| March 26, 2026 | 42.64B |
| March 25, 2026 | 44.58B |
| March 24, 2026 | 44.01B |
| March 23, 2026 | 44.43B |
| March 20, 2026 | 44.17B |
| March 19, 2026 | 43.45B |
| March 18, 2026 | 42.07B |
| March 17, 2026 | 42.02B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 282.66B |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 6.446M |
| Oculis Holding AG | 660.04M |
| Sandoz Group AG | -- |
Market Cap Related Metrics
| PE Ratio | 78.29 |
| PS Ratio | 9.224 |
| Price to Free Cash Flow | 46.59 |
| Price | 202.50 |
| Earnings Yield | 1.28% |
| Operating PE Ratio | 56.84 |
| Normalized PE Ratio | 70.77 |